Related Experiment Videos
[Principles for assessing and correcting secondary immunological deficiency].
Terapevticheskii Arkhiv
|January 1, 1984
Summary
Sodium nucleinate improved immune deficiency in patients with various diseases, including bronchopulmonary conditions and peptic ulcers. This treatment promoted disease remission by correcting T-cell immunity.
Area of Science:
- Immunology
- Internal Medicine
- Biochemistry
Context:
- Immune deficiency is prevalent in patients with bronchopulmonary diseases, rheumatic fever, peptic ulcer, hypertension, and chronic alcoholism.
- T-cell immunity is particularly affected in these patient populations.
- A correlation between blood serum RNA and immunological characteristics was observed in peptic ulcer patients.
Purpose:
- To investigate the role of sodium nucleinate in managing immune deficiency.
- To assess the impact of sodium nucleinate on disease remission in patients with multiple comorbidities.
- To explore the relationship between RNA levels and immune status in peptic ulcer disease.
Summary:
- A study involving 923 patients identified immune deficiency, especially in the T-cell system, across various conditions.
- Incorporating sodium nucleinate into comprehensive treatment plans led to the correction of immune deficiency.
- This intervention resulted in the remission of underlying diseases, demonstrating therapeutic efficacy.
Impact:
- Sodium nucleinate shows potential as an immunomodulatory agent in treating complex diseases.
- The findings suggest a therapeutic strategy for improving immune function and clinical outcomes.
- Further research into RNA's role in immune regulation may offer new diagnostic and therapeutic avenues.